It is also noted that the sensitivity of the assays utilised through the TGCA data and the present cohorts differ; however, it is not likely that the differences in mutational prevalence are driven by this with highly significant variances identified.
← all excerpts
Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders.
1
—
—